Literature DB >> 30943350

Glucocorticoid-Induced Osteoporosis.

Manuel Sosa1, M Jesús Gómez de Tejada2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30943350     DOI： 10.1056/NEJMc1901239

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  How we can mitigate the side effects associated with systemic glucocorticoid after allogeneic hematopoietic cell transplantation.

Authors:  Shigeo Fuji; Michael Byrne; Arnon Nagler; Mohamad Mohty; Bipin N Savani
Journal:  Bone Marrow Transplant       Date:  2021-01-29       Impact factor: 5.174

2.  Risk factor analysis of nosocomial lower respiratory tract infection in influenza-related acute respiratory distress syndrome.

Authors:  Wei-Chih Chen; Kuo-Chin Kao; Chau-Chyun Sheu; Ming-Cheng Chan; Yu-Mu Chen; Ying-Chun Chien; Chung-Kan Peng; Shinn-Jye Liang; Han-Chung Hu; Ming-Ju Tsai; Wen-Feng Fang; Wann-Cherng Perng; Hao-Chien Wang; Chieh-Liang Wu; Kuang-Yao Yang
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

3.  A novel biomimetic nanomedicine system with anti-inflammatory and anti-osteoporosis effects improves the therapy efficacy of steroid-resistant nephrotic syndrome.

Authors:  Jian Li; Mingyi Zhao; Xinying Xiang; Qingnan He; Rong Gui
Journal:  J Nanobiotechnology       Date:  2021-12-13       Impact factor: 10.435

4.  Nicotinamide mononucleotide attenuates glucocorticoid‑induced osteogenic inhibition by regulating the SIRT1/PGC‑1α signaling pathway.

Authors:  Rui-Xiong Huang; Jun Tao
Journal:  Mol Med Rep       Date:  2020-05-04       Impact factor: 2.952
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.